Neuromuscular Blockade During Transurethral Resection of Bladder Cancer
Status:
Completed
Trial end date:
2017-11-10
Target enrollment:
Participant gender:
Summary
Transurethral resection of the bladder tumor (TURB) for bladder tumor excision is the
mainstream treatment. However, the beneficial effects of sugammadex after general anesthesia
for TURB have not been thoroughly evaluated. Investigators hypothesized that deep NMB and the
use of sugammadex as a reversal agent may be associated with better endoscopic surgical
condition and recovery profile compared with moderate NMB during TURB.
This study was designed to compare patients with deep neuromuscular blockade (NMB) with
moderate NMB during transurethral resection of the bladder tumor (TURB) in terms of surgical
condition and postoperative recovery.